227 related articles for article (PubMed ID: 16806276)
1. Dynamics, stability and inheritance of somatic DNA methylation imprints.
Sontag LB; Lorincz MC; Georg Luebeck E
J Theor Biol; 2006 Oct; 242(4):890-9. PubMed ID: 16806276
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic programming of differential gene expression in development and evolution.
Monk M
Dev Genet; 1995; 17(3):188-97. PubMed ID: 8565325
[TBL] [Abstract][Full Text] [Related]
3. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
4. Developmental regulation of somatic imprints.
John RM; Lefebvre L
Differentiation; 2011 Jun; 81(5):270-80. PubMed ID: 21316143
[TBL] [Abstract][Full Text] [Related]
5. Lsh controls silencing of the imprinted Cdkn1c gene.
Fan T; Hagan JP; Kozlov SV; Stewart CL; Muegge K
Development; 2005 Feb; 132(4):635-44. PubMed ID: 15647320
[TBL] [Abstract][Full Text] [Related]
6. The epigenetics of oral cancer.
Shaw R
Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
[TBL] [Abstract][Full Text] [Related]
7. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA.
Sharif J; Muto M; Takebayashi S; Suetake I; Iwamatsu A; Endo TA; Shinga J; Mizutani-Koseki Y; Toyoda T; Okamura K; Tajima S; Mitsuya K; Okano M; Koseki H
Nature; 2007 Dec; 450(7171):908-12. PubMed ID: 17994007
[TBL] [Abstract][Full Text] [Related]
8. Genomic patterns of DNA methylation: targets and function of an epigenetic mark.
Weber M; Schübeler D
Curr Opin Cell Biol; 2007 Jun; 19(3):273-80. PubMed ID: 17466503
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation: the nuts and bolts of repression.
Miranda TB; Jones PA
J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and hepatocellular carcinoma.
Zhu J
J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
[TBL] [Abstract][Full Text] [Related]
11. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.
Schlesinger Y; Straussman R; Keshet I; Farkash S; Hecht M; Zimmerman J; Eden E; Yakhini Z; Ben-Shushan E; Reubinoff BE; Bergman Y; Simon I; Cedar H
Nat Genet; 2007 Feb; 39(2):232-6. PubMed ID: 17200670
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
Tost J
Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation, imprinting and cancer.
Plass C; Soloway PD
Eur J Hum Genet; 2002 Jan; 10(1):6-16. PubMed ID: 11896451
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
15. Cooperative interactions between epigenetic modifications and their function in the regulation of chromosome architecture.
Weissmann F; Lyko F
Bioessays; 2003 Aug; 25(8):792-7. PubMed ID: 12879449
[TBL] [Abstract][Full Text] [Related]
16. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
[TBL] [Abstract][Full Text] [Related]
17. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
[TBL] [Abstract][Full Text] [Related]
18. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
19. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
